Study in Patients With COPD
1 other identifier
interventional
690
1 country
68
Brief Summary
The purpose of this study is to determine the efficacy and safety of the investigational drug in the treatment of COPD in comparison with a placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
68 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 13, 2005
CompletedFirst Posted
Study publicly available on registry
September 22, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2006
CompletedNovember 11, 2010
January 1, 2009
September 13, 2005
November 10, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Measure of lung function
Secondary Outcomes (2)
Change in lung function, as well as vital signs
Physical Exam results, Adverse Event reporting, etc
Interventions
Eligibility Criteria
You may qualify if:
- Medical diagnosis of COPD
- Current or prior history of cigarette smoking
You may not qualify if:
- Medical diagnosis of asthma
- Chest x-ray (CXR) prior to Day 1 diagnostic of significant disease other than COPD
- Significant condition or disease other than COPD
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Deylead
Study Sites (68)
Research Site
Bessemer, Alabama, 35023, United States
Research Site
Birmingham, Alabama, 35209, United States
Research Site
Phoenix, Arizona, 85006-2666, United States
Research Site
Tuscon, Arizona, 85715, United States
Research Site
Tuscon, Arizona, 85723, United States
Research Site
Tuscon, Arizona, 85745, United States
Research Site
Buena Park, California, 90620, United States
Research Site
Encinitas, California, 92024, United States
Research Site
Huntington Beach, California, 92647, United States
Research Site
Los Angeles, California, 90048, United States
Research Site
Los Angeles, California, 90095, United States
Research Site
Mission Viejo, California, 92691, United States
Research Site
San Diego, California, 92120, United States
Research Site
Sepulveda, California, 91343, United States
Research Site
Stockton, California, 95207, United States
Research Site
Walnut Creek, California, 94598, United States
Research Site
Colorado Springs, Colorado, 80907, United States
Research Site
Denver, Colorado, 80206, United States
Research Site
Wheat Ridge, Colorado, 80033, United States
Research Site
Hartford, Connecticut, 06105, United States
Research Site
Waterbury, Connecticut, 06708, United States
Research Site
Bay Pines, Florida, 33744, United States
Research Site
Clearwater, Florida, 33765, United States
Research Site
DeLand, Florida, 32720, United States
Research Site
Tampa, Florida, 33607, United States
Research Site
Atlanta, Georgia, 30342, United States
Research Site
Blue Ridge, Georgia, 30513, United States
Research Site
Hines, Illinois, 60141, United States
Research Site
Normal, Illinois, 61761, United States
Research Site
Evansville, Indiana, 47714, United States
Research Site
Shawnee Mission, Kansas, 66216, United States
Research Site
Topeka, Kansas, 66606, United States
Research Site
Louisville, Kentucky, 40215, United States
Research Site
New Orleans, Louisiana, 70115, United States
Research Site
Slidell, Louisiana, 70461, United States
Research Site
Edina, Minnesota, 55438, United States
Research Site
Minneapolis, Minnesota, 55402, United States
Research Site
Minneapolis, Minnesota, 55407, United States
Research Site
Minneapolis, Minnesota, 55416, United States
Research Site
Rochester, Minnesota, 55905, United States
Research Site
Butte, Montana, 59701, United States
Research Site
Omaha, Nebraska, 68134, United States
Research Site
Papillion, Nebraska, 68046, United States
Research Site
Henderson, Nevada, 89014, United States
Research Site
Cherry Hill, New Jersey, 08003, United States
Research Site
Springfield, New Jersey, 07081, United States
Research Site
Albuquerque, New Mexico, 87108, United States
Research Site
Larchmont, New York, 10538, United States
Research Site
New Hyde Park, New York, 11040, United States
Research Site
Chapel Hill, North Carolina, 27599, United States
Research Site
Cincinnati, Ohio, 45219, United States
Research Site
Cincinnati, Ohio, 45220, United States
Research Site
Cincinnati, Ohio, 45231, United States
Research Site
Cincinnati, Ohio, 45241, United States
Research Site
Cincinnati, Ohio, 45245, United States
Research Site
Columbus, Ohio, 43215, United States
Research Site
Medford, Oregon, 97504, United States
Research Site
Portland, Oregon, 97213, United States
Research Site
Easton, Pennsylvania, 18045, United States
Research Site
Spartanburg, South Carolina, 29307, United States
Research Site
Austin, Texas, 78750, United States
Research Site
El Paso, Texas, 79902, United States
Research Site
Houston, Texas, 77024, United States
Research Site
Houston, Texas, 77030, United States
Research Site
San Antonio, Texas, 78229, United States
Research Site
Richmond, Virginia, 23225, United States
Research Site
Madison, Wisconsin, 53792, United States
Research Site
Milwaukee, Wisconsin, 53209, United States
Related Publications (1)
Donohue JF, Hanania NA, Fogarty C, Campbell SC, Rinehart M, Denis-Mize K. Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial. Ther Adv Respir Dis. 2008 Aug;2(4):199-208. doi: 10.1177/1753465808093934.
PMID: 19124372RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
September 13, 2005
First Posted
September 22, 2005
Primary Completion
December 1, 2005
Study Completion
April 1, 2006
Last Updated
November 11, 2010
Record last verified: 2009-01